Navigation Links
PharmaNet Extends Consent Payment Deadline for Notes Tendered in Its Tender Offer and Consent Solicitation
Date:6/10/2011

ligation to update any forward-looking statements as a result of developments occurring after the date of this press release, except, with respect to the Offer, as specifically set forth in this press release or as otherwise required by law.Contact:

Lilian G. Burke PharmaNet Development Group, Inc.609-951-6839www.pharmanet.com  
'/>"/>

SOURCE PharmaNet Development Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. PharmaNet Announces Tender Offer and Consent Solicitation
2. PharmaNet to Present More Than 20 Posters at the 2010 American Association of Pharmaceutical Scientists Annual Meeting
3. PharmaNet Development Group Experts to Share Insights at the 9th Annual Partnerships in Clinical Trials Conference in Vienna
4. PharmaNet Development Group Appoints Anthony Maida, Vice President, Clinical Research
5. Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer
6. SEC Closes Investigation of PharmaNet Development Group and Recommends No Action
7. Christopher Brennan Joins PharmaNet Development Group as General Counsel
8. PharmaNet Development Group Provides Financial Update and Announces Geographic Expansion
9. PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June
10. PharmaNet Development Group Gives Notice of Anticipated Fundamental Change and Merger to Holders of Its Convertible Notes
11. PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013 The ability ... deciphering the information they encode. There are now ... (deep sequencing of ribosome protected fragments) that dramatically ... , Keynote speakers include Dr. Jonathan Weissman, an ... the Howard Hughes Medical Institute, who will present ...
(Date:5/21/2013)... NEW YORK , May 21, 2013  The Lindsley ... announced today that it is a Grand Challenges Explorations ... Melinda Gates Foundation .  Dr. Sara Lustigman ... an innovative global health and development research project, titled ... worms.  These worms are needed to screen drugs to ...
(Date:5/21/2013)... 21, 2013 Alpha Source, Inc., ... will be exhibiting for the 13th consecutive year ... Instrumentation (AAMI) 2013 Conference and Expo. The conference ... and manufacture healthcare technologies. This year’s event will ... California. , The three-day event draws over ...
(Date:5/21/2013)... TX (PRWEB) May 21, 2013 Smarter ... outdoor security solutions, today announced that Genzyme, a Sanofi ... units of Door Detective® CL for a multi-use facility ... installed in four other Genzyme buildings, this latest order ... with the tailgate detection device improving doorway ...
Breaking Biology Technology:Monitoring Protein Synthesis One Codon at a Time Through Ribosome Profiling, a Webinar Hosted by Xtalks 2New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 2New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 3Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3
... Pharmaceuticals, Inc. (Nasdaq: ANTH ), a ... associated with abnormal auto-immune responses and inflammation, today ... Officer, will present at Citi,s 2011 Global Health ... March 1, 2011, at approximately 1:30 pm Eastern ...
... revenues totaled 153.5 million euro in 2010 (approximately 211.4 ... million euro, or approximately 169.9 million USD). This performance ... Yondelis® sales. Net sales in the Biopharmaceutical ... USD) in 2010 (51.1 million euro, or approximately 70.3 ...
... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that a study ... Pathology demonstrated the ability of the ... of the highest risk HPV genotypes causing 70 percent of cervical ... study, which involved more than 47,000 women, validates the cobas ...
Cached Biology Technology:74 Percent EBITDA Improvement at Zeltia Group in 2010 2Pivotal Study Validates Roche's cobas® HPV Test with HPV-16 and 18 Genotyping for Identifying Women at Highest Risk for Cervical Cancer 2Pivotal Study Validates Roche's cobas® HPV Test with HPV-16 and 18 Genotyping for Identifying Women at Highest Risk for Cervical Cancer 3
(Date:5/21/2013)... Cancers of all types become most deadly when they ... has reached this stage, it becomes very difficult for ... can develop. Now, researchers at the University of Missouri ... target lymphoma tumor cells wherever they may be in ... in the MU College of Veterinary Medicine, says being ...
(Date:5/21/2013)... Chemical Society (ACS), the world,s largest scientific society, ... Meeting & Exposition, September 8-12, 2013, in Indianapolis, ... Convention Center and at area hotels. , With ... span science,s horizons from astronomy to zoology ... online journalists a rich assortment of spot news ...
(Date:5/21/2013)... modifications, which alter the way genes function without ... detected in the blood of pregnant women during ... foretell depression in the weeks after giving birth, ... debilitating. , The findings of the small study ... the journal Molecular Psychiatry . , "Postpartum ...
Breaking Biology News(10 mins):MU researchers develop radioactive nanoparticles that target cancer cells 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3
... has captured another image of Iceland,s Eyjafjallajkull volcano ash ... ash into the air and the ash clouds are ... Terra satellite flew over the volcano on April 16 ... Resolution Imaging Spectroradiometer, or MODIS instrument aboard Terra captured ...
... have found a way to determine which somatic cells -- ... a primordial, embryonic-like state are the most viable for therapeutic ... the Journal of Biological Chemistry, two collaborating teams ... a marker they found in induced-pluripotent stem cells, or iPS ...
... Vienna, Austria, Friday 16 April 2010: Results from ... CongressTM 2010 press conference will help inform clinical practice ... alcoholic hepatitis. The first study demonstrated the ... from severe alcoholic hepatitis (SAH) earlier than the recommended ...
Cached Biology News:Chinese scientists discover marker indicating the developmental potential of stem cells 2New insights into treatment options for patients suffering from severe alcoholic hepatitis 2
... a high performance spectral scanning multimode ... With the advanced SkanIt Software it ... drug discovery assay development. Varioskan provides ... time-resolved fluorescence and photometric assays and ...
Strip Removal Tool 25/Box...
Oven mesh sheets, large, 23 x 23cm, pack of 5...
... Protein Phosphatase ( l-PPase) ... phosphatase with activity towards ... tyrosine residues. It is ... of the ORF221 open ...
Biology Products: